Merck’s 2025 guidance fell short of Wall Street expectations. Photo: Spencer Platt/Getty Images Investors have taken to punishing pharma companies that appear unable to gauge demand for their ...

1 day ago · Merck said it expected sales of $64.1 billion to $65.5 billion in 2025 and adjusted earnings of $8.88 to $9.03 a share. Both forecasts came in below the average analyst expectation for revenue of ...

The company’s revenue was $15.62 billion, beating Wall Street forecasts of $15.55 billion. For fiscal 2025, MRK expects full-year adjusted EPS to be between $8.88 and $9.03, and expects revenue ...

1 day ago · Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, although the drug company’s outlook for 2025 and a slide in sales of its HPV vaccine hit shares.

16 hours ago · In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against the other stocks. Wall Street’s main indices all finished in the green territory on Tuesday ...

1 day ago · Here's what Merck reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: $1.72 adjusted vs. $1.62 expected Revenue ...

Find the latest Merck & Co., Inc. (MRK) stock quote, history, news and other vital information to help you with your stock trading and investing.

1 day ago · Merck swung to a quarterly profit as sales grew to beat Wall Street's estimates, though the drug company's outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares. The ...

2 days ago · For the quarter ended December 2024, Merck (MRK) reported revenue of $15.62 billion, up 6.8% over the same period last year. EPS came in at $1.72, compared to $0.03 in the year-ago quarter. The ...

6 days ago · Wall Street analysts forecast that Merck (MRK) will report quarterly earnings of $1.69 per share in its upcoming release, pointing to a year-over-year increase of 5533.3%.